EVARF OTC
Lombard Medical, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -0.0%
5Y: -98.6%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$12M
-19.5% ▼
Gross Profit
$955K
-85.4% ▼
Operating Income
-$29M
+25.7% ▲
Net Income
-$31M
+17.9% ▲
EPS (Diluted)
$-1.54
+27.7% ▲
EBITDA
-$28M
+24.9% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2015 | FY2016 |
|---|---|---|
| Revenue | $15M | $12M |
| YoY Growth | +0.0% | -19.5% |
| Cost of Revenue | $9M | $11M |
| Gross Profit | $7M | $955K |
| Gross Margin | 43.4% | 7.8% |
| R&D Expenses | $11M | $7M |
| SG&A Expenses | $35M | $23M |
| Operating Expenses | $46M | $30M |
| Operating Income | -$39M | -$29M |
| Operating Margin | -261.1% | -241.1% |
| Interest Expense | $860K | $2M |
| Income Before Tax | -$40M | -$33M |
| Tax Expense | -$2M | -$1M |
| Net Income | -$38M | -$31M |
| Net Margin | -250.1% | -255.0% |
| EPS (Diluted) | $-2.13 | $-1.54 |
| EBITDA | -$37M | -$28M |
| Shares Outstanding | 18M | 20M |